Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning

Abstract Background We evaluated the role of radiomics applied to contrast-enhanced computed tomography (CT) in the detection of lymph node (LN) metastases in patients with known lung cancer compared to 18F-fluorodeoxyglucose positron emission tomography (PET)/CT as a reference. Methods This retrosp...

Full description

Bibliographic Details
Main Authors: Boris Gorodetski, Philipp Hendrik Becker, Alexander Daniel Jacques Baur, Alexander Hartenstein, Julian Manuel Michael Rogasch, Christian Furth, Holger Amthauer, Bernd Hamm, Marcus Makowski, Tobias Penzkofer
Format: Article
Language:English
Published: SpringerOpen 2022-09-01
Series:European Radiology Experimental
Subjects:
Online Access:https://doi.org/10.1186/s41747-022-00296-8
_version_ 1798000648292139008
author Boris Gorodetski
Philipp Hendrik Becker
Alexander Daniel Jacques Baur
Alexander Hartenstein
Julian Manuel Michael Rogasch
Christian Furth
Holger Amthauer
Bernd Hamm
Marcus Makowski
Tobias Penzkofer
author_facet Boris Gorodetski
Philipp Hendrik Becker
Alexander Daniel Jacques Baur
Alexander Hartenstein
Julian Manuel Michael Rogasch
Christian Furth
Holger Amthauer
Bernd Hamm
Marcus Makowski
Tobias Penzkofer
author_sort Boris Gorodetski
collection DOAJ
description Abstract Background We evaluated the role of radiomics applied to contrast-enhanced computed tomography (CT) in the detection of lymph node (LN) metastases in patients with known lung cancer compared to 18F-fluorodeoxyglucose positron emission tomography (PET)/CT as a reference. Methods This retrospective analysis included 381 patients with 1,799 lymph nodes (450 malignant, 1,349 negative). The data set was divided into a training and validation set. A radiomics analysis with 4 filters and 6 algorithms resulting in 24 different radiomics signatures and a bootstrap algorithm (Bagging) with 30 bootstrap iterations was performed. A decision curve analysis was applied to generate a net benefit to compare the radiomics signature to two expert radiologists as one-by-one and as a prescreening tool in combination with the respective radiologist and only the radiologists. Results All 24 modeling methods showed good and reliable discrimination for malignant/benign LNs (area under the curve 0.75−0.87). The decision curve analysis showed a net benefit for the least absolute shrinkage and selection operator (LASSO) classifier for the entire probability range and outperformed the expert radiologists except for the high probability range. Using the radiomics signature as a prescreening tool for the radiologists did not improve net benefit. Conclusions Radiomics showed good discrimination power irrespective of the modeling technique in detecting LN metastases in patients with known lung cancer. The LASSO classifier was a suitable diagnostic tool and even outperformed the expert radiologists, except for high probabilities. Radiomics failed to improve clinical benefit as a prescreening tool.
first_indexed 2024-04-11T11:23:41Z
format Article
id doaj.art-5b6e5baefbba4665bbd3cca80eaa9811
institution Directory Open Access Journal
issn 2509-9280
language English
last_indexed 2024-04-11T11:23:41Z
publishDate 2022-09-01
publisher SpringerOpen
record_format Article
series European Radiology Experimental
spelling doaj.art-5b6e5baefbba4665bbd3cca80eaa98112022-12-22T04:26:22ZengSpringerOpenEuropean Radiology Experimental2509-92802022-09-016111510.1186/s41747-022-00296-8Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learningBoris Gorodetski0Philipp Hendrik Becker1Alexander Daniel Jacques Baur2Alexander Hartenstein3Julian Manuel Michael Rogasch4Christian Furth5Holger Amthauer6Bernd Hamm7Marcus Makowski8Tobias Penzkofer9Department of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Nuclear Medicine, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Nuclear Medicine, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Nuclear Medicine, Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumDepartment of Radiology (including Pediatric Radiology), Charité–Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Campus Virchow-KlinikumAbstract Background We evaluated the role of radiomics applied to contrast-enhanced computed tomography (CT) in the detection of lymph node (LN) metastases in patients with known lung cancer compared to 18F-fluorodeoxyglucose positron emission tomography (PET)/CT as a reference. Methods This retrospective analysis included 381 patients with 1,799 lymph nodes (450 malignant, 1,349 negative). The data set was divided into a training and validation set. A radiomics analysis with 4 filters and 6 algorithms resulting in 24 different radiomics signatures and a bootstrap algorithm (Bagging) with 30 bootstrap iterations was performed. A decision curve analysis was applied to generate a net benefit to compare the radiomics signature to two expert radiologists as one-by-one and as a prescreening tool in combination with the respective radiologist and only the radiologists. Results All 24 modeling methods showed good and reliable discrimination for malignant/benign LNs (area under the curve 0.75−0.87). The decision curve analysis showed a net benefit for the least absolute shrinkage and selection operator (LASSO) classifier for the entire probability range and outperformed the expert radiologists except for the high probability range. Using the radiomics signature as a prescreening tool for the radiologists did not improve net benefit. Conclusions Radiomics showed good discrimination power irrespective of the modeling technique in detecting LN metastases in patients with known lung cancer. The LASSO classifier was a suitable diagnostic tool and even outperformed the expert radiologists, except for high probabilities. Radiomics failed to improve clinical benefit as a prescreening tool.https://doi.org/10.1186/s41747-022-00296-8Machine learningLymph nodesLymphatic metastasisLung neoplasmsTomography (x-ray computed)
spellingShingle Boris Gorodetski
Philipp Hendrik Becker
Alexander Daniel Jacques Baur
Alexander Hartenstein
Julian Manuel Michael Rogasch
Christian Furth
Holger Amthauer
Bernd Hamm
Marcus Makowski
Tobias Penzkofer
Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
European Radiology Experimental
Machine learning
Lymph nodes
Lymphatic metastasis
Lung neoplasms
Tomography (x-ray computed)
title Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
title_full Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
title_fullStr Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
title_full_unstemmed Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
title_short Inferring FDG-PET-positivity of lymph node metastases in proven lung cancer from contrast-enhanced CT using radiomics and machine learning
title_sort inferring fdg pet positivity of lymph node metastases in proven lung cancer from contrast enhanced ct using radiomics and machine learning
topic Machine learning
Lymph nodes
Lymphatic metastasis
Lung neoplasms
Tomography (x-ray computed)
url https://doi.org/10.1186/s41747-022-00296-8
work_keys_str_mv AT borisgorodetski inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT philipphendrikbecker inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT alexanderdanieljacquesbaur inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT alexanderhartenstein inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT julianmanuelmichaelrogasch inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT christianfurth inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT holgeramthauer inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT berndhamm inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT marcusmakowski inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning
AT tobiaspenzkofer inferringfdgpetpositivityoflymphnodemetastasesinprovenlungcancerfromcontrastenhancedctusingradiomicsandmachinelearning